Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Bander

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
The Prostate|January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancerPanagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Molecular Cancer Research : MCR|July 27, 2016
Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular CompartmentDaniel P Nguyen, Peter L Xiong, He Liu, et al.
Frontiers in Oncology|March 8, 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate CancerPanagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, et al.
EJNMMI Research|May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumorsNeeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.
Cancer|April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (<sup>177</sup> Lu-J591) for metastatic castration-resistant prostate cancerScott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.
Human Pathology|September 1, 2009
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancersMichael C Haffner, Irmgard E Kronberger, Jeffrey S Ross, et al.
Molecular Cancer Therapeutics|June 13, 2018
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot FormulationWilhem Leconet, He Liu, Ming Guo, et al.
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
The Prostate|January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancerPanagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Molecular Cancer Research : MCR|July 27, 2016
Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular CompartmentDaniel P Nguyen, Peter L Xiong, He Liu, et al.
Frontiers in Oncology|March 8, 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate CancerPanagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, et al.
EJNMMI Research|May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumorsNeeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.
Cancer|April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (<sup>177</sup> Lu-J591) for metastatic castration-resistant prostate cancerScott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.
Human Pathology|September 1, 2009
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancersMichael C Haffner, Irmgard E Kronberger, Jeffrey S Ross, et al.
Molecular Cancer Therapeutics|June 13, 2018
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot FormulationWilhem Leconet, He Liu, Ming Guo, et al.
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.
Pageof 9